Psychiatric And Sexual Dysfunction Warnings Strengthened For Finasteride And Dutasteride
January 2026
in “
Pharmaceutical journal/The pharmaceutical journal
”
Studysummary The MHRA announced on 11 May 2026 that it will update the product information for finasteride and dutasteride to include more details on potential psychiatric and sexual side effects, following a review of existing evidence.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →